▶️ AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants: Study
▶️ Singapore’s GIC to invest $180 million in Sunway’s healthcare unit
▶️ Additional 61,120 vials of Liposomal Amphotericin B allocated to all States/UTs: D.V Sadananda Gowda
▶️ Indian SARS-CoV-2 Genomic Consortia has tagged the new Delta Plus strain as a “Variant of Concern”.
▶️ Mankind Pharma launches Justoza, a Dapagliflozin approved by USFDA.
▶️ Pfizer in ‘final stages’ of getting approval for Covid-19 vaccine in India: CEO
▶️ Switching from Western diet to a balanced diet may reduce skin, joint inflammation: Study
▶️ Oxford University explores anti-parasitic drug ivermectin as Covid-19 treatment.
▶️ Piramal Pharma completes acquisition of Hemmo Pharmaceuticals.
Share your important news at news.healthinfive@gmail.com
Follow Health In Five on LinkedIn, Facebook, Twitter & Instagram
Subscribe on WhatsApp & Telegram to receive real time updates
